Results 41 to 50 of about 3,199 (152)

The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis [PDF]

open access: yes, 2016
Objective. To establish cutoffs for the minimum clinically important improvement (MCII) and the patient-acceptable symptom state (PASS) for the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional ...
Tubach, Florence   +35 more
core   +1 more source

Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity

open access: yesRheumatology
Axial spondyloarthritis (axSpA) is an inflammatory joint disease, in which the dominant symptom is inflammatory back pain. It affects approximately 1% of the population, with a higher incidence in males.
Katarzyna Małgorzata Wiąk-Walerowicz   +1 more
doaj   +1 more source

OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS [PDF]

open access: yesRomanian Journal of Rheumatology, 2016
Background/Objective. Disease activity in spondyloarthritis (SpA) is evaluated through conventional scores such as BASDAI or ASDAS. The aim of this study was to determine disease activity in SpA patients under biological therapy with further assessment ...
Claudia Deaconu   +13 more
doaj   +1 more source

POS0344 BASDAI CUT-OFFS FOR DISEASE ACTIVITY CORRESPONDING TO ASDAS-ESR CUT-OFFS IN AXIAL SPONDYLARTHRITIS – RESULTS FROM THE EUROSPA COLLABORATION

open access: yes, 2023
BackgroundThe Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is often used for classifying patients according to disease activity states.
Michelsen, B.   +24 more
core   +1 more source

Generating EQ-5D-5L health utility scores from BASDAI and BASFI:a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data [PDF]

open access: yes, 2022
BACKGROUND: Preference-based health-state utility values (HSUVs), such as the EuroQol five-dimensional questionnaire (EQ-5D-5L), are needed to calculate quality-adjusted life-years (QALYs) for cost-effectiveness analyses.
Jones, Gareth T   +8 more
core   +1 more source

Axial spondyloarthritis in men and women

open access: yesНаучно-практическая ревматология
The work of recent decades has changed the idea that axial spondylitis (axSpA) is an exclusively “male” disease. However, at present, when deciding on further treatment tactics, gender differences in the course of the disease and response to treatment ...
E. V. Ilinykh   +8 more
doaj   +1 more source

Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis

open access: yesFrontiers in Medicine, 2022
BackgroundTo evaluate gender differences in disease activity and health status (HS) in patients with radiographic axial spondyloarthritis (r-axSpA)/ankylosing spondylitis (AS).MethodsAncillary analysis of the MIDAS study, an observational, non ...
Cristina Fernández-Carballido   +9 more
doaj   +1 more source

BASDAI and BASFI scores in patients with IL-12B genotypes.

open access: yes, 2015
BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index.* Adjusting the effects of age, sex, disease duration.BASDAI and BASFI scores in patients with IL-12B genotypes.
Xiao Yang (19898)   +15 more
core   +1 more source

Examining the Interchangeability of Two Different Patient‐Reported Global Assessment Measures in an Observational Axial Spondyloarthritis Cohort

open access: yesArthritis Care &Research, EarlyView.
Objective The goal of this study was to determine if patient global assessment (PGA) scores reported by patients with axial spondyloarthritis (AxSpA) before the development of the AxSpA Disease Activity Score (ASDAS) can be used as a substitute for the global item of the ASDAS formula.
Connor Vershel   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy